Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease courseAlexandra Domnica Hoeggerl, Sandra Laner‐Plamberger, Eva Rohde et al.|BMC Infectious Diseases|2023Cited by 19
Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after InfectionVerena Nunhofer, Sandra Laner‐Plamberger, Lisa Weidner et al.|Viruses|2022Cited by 18
Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infectionAlexandra Domnica Hoeggerl, Sandra Laner‐Plamberger, Verena Nunhofer et al.|Scandinavian Journal of Infectious Diseases|2024Cited by 7
Stable <scp>SARS</scp>‐<scp>CoV</scp>‐2 antibody levels and functionality in serum and <scp>COVID</scp>‐19 convalescent plasma after long‐term storageSandra Laner‐Plamberger, Christoph Grabmer, Anita Siller et al.|Vox Sanguinis|2025Cited by 3
SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor SuitabilitySandra Laner‐Plamberger, Christoph Grabmer, Lisa Weidner et al.|Diagnostics|2022Cited by 2